Elavil and Diamox drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Elavil (amitriptyline hydrochloride) and Diamox (acetazolamide). Common drug interactions include pulmonary embolism among females and anhedonia among males.

The phase IV clinical study analyzes what interactions people have when they take Elavil and Diamox. It is created by eHealthMe based on reports of 24 people who take the same drugs from the FDA, and is updated regularly.

What is Elavil?

Elavil has active ingredients of amitriptyline hydrochloride. It is often used in depression. eHealthMe is studying from 20,724 Elavil users. Check the latest studies of Elavil.

What is Diamox?

Diamox has active ingredients of acetazolamide. It is often used in pseudotumor cerebri. eHealthMe is studying from 4,711 Diamox users. Check the latest studies of Diamox.



On Jul, 17, 2026

24 people who take Elavil and Diamox together, and have interactions are studied.

Elavil and Diamox drug interactions.

What are the common drug interactions of Elavil and Diamox, by gender? *:

female:

  1. Pulmonary embolism (blockage of the main artery of the lung)
  2. Renal failure acute (rapid kidney dysfunction)
  3. Renal failure chronic (long lasting kidney dysfunction)
  4. Retinopathy (acute damage to the retina of the eye)
  5. Tibia fracture (fracture of lower leg bone)
  6. Transient ischaemic attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow))
  7. Vena cava thrombosis (clotting of the blood in large vein carrying deoxygenated blood into the heart)
  8. Abdominal compartment syndrome (increased pressure in abdomen)
  9. Adrenal insufficiency (a condition in which the adrenal glands do not produce adequate amounts of steroids)
  10. Ascites (accumulation of fluid in the abdominal cavity)

male:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Bone pain
  4. Breakthrough pain
  5. Cholecystitis infective (infection of gallbladder capable to infect other organs)
  6. Chronic kidney disease
  7. Decreased appetite
  8. Excessive granulation tissue (excessive collagen-rich tissue which forms at the site of an injury)
  9. General physical health deterioration (weak health status)
  10. Gingival disorder (gum disease)

What are the common drug interactions of Elavil and Diamox, by age (0-1 to 60+)? *:

0-1:

  1. Abdominal compartment syndrome (increased pressure in abdomen)
  2. Ascites (accumulation of fluid in the abdominal cavity)
  3. Blood lactic acid increased
  4. Cholecystitis (infection of gallbladder)
  5. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  6. Coagulopathy (blood's ability to clot is impaired)
  7. Duodenal perforation (complication of duodenal ulcer)
  8. Enterococcal infection
  9. Fluid retention (an abnormal accumulation of fluid in the blood)
  10. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)

2-9:

n/a

10-19:

  1. Anxiety
  2. Emotional distress
  3. General physical health deterioration (weak health status)
  4. Injury
  5. Jugular vein thrombosis (clot in jugular vein)
  6. Pain
  7. Pulmonary embolism (blockage of the main artery of the lung)
  8. Vena cava thrombosis (clotting of the blood in large vein carrying deoxygenated blood into the heart)
  9. Bile duct stone
  10. Cholecystitis chronic (long lasting infection of gallbladder)

20-29:

n/a

30-39:

  1. Hyperhidrosis (abnormally increased sweating)
  2. Injection site pain
  3. Intracranial pressure increased (high pressure inside the skull and thus in the brain tissue and cerebrospinal fluid)
  4. Loss of employment
  5. Lower respiratory tract infection
  6. Malaise (a feeling of general discomfort or uneasiness)
  7. Mitral valve incompetence (inefficient heart valve)
  8. Muscle spasms (muscle contraction)
  9. Muscle tightness
  10. Muscular weakness (muscle weakness)

40-49:

  1. Chronic kidney disease
  2. Death
  3. Contusion (a type of hematoma of tissue in which capillaries)
  4. Dysphagia (a condition in which swallowing is difficult or painful)
  5. Fatigue (feeling of tiredness)
  6. Fungal infection

50-59:

  1. Cardiac failure congestive
  2. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  3. Macular oedema (fluid and protein deposits collect on or under the macula of the eye (a yellow central area of the retina) and causes it to thicken)
  4. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  5. Renal failure acute (rapid kidney dysfunction)
  6. Renal failure chronic (long lasting kidney dysfunction)
  7. Retinopathy (acute damage to the retina of the eye)
  8. Tibia fracture (fracture of lower leg bone)
  9. Transient ischaemic attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow))
  10. Chronic kidney disease

60+:

  1. Pneumonia
  2. Abdominal distension
  3. Breakthrough pain
  4. Cholecystitis infective (infection of gallbladder capable to infect other organs)
  5. Decreased appetite
  6. Dizziness
  7. Dyspnoea (difficult or laboured respiration)
  8. Excessive granulation tissue (excessive collagen-rich tissue which forms at the site of an injury)
  9. General physical health deterioration (weak health status)
  10. Gingival disorder (gum disease)

What are the existing conditions these people have? *

  1. Seizures (abnormal excessive or synchronous neuronal activity in the brain): 3 people, 12.50%
  2. Prostate Cancer: 3 people, 12.50%
  3. Oedema (fluid collection in tissue): 3 people, 12.50%
  4. Malaria (a parasitic disease due to mosquito bite): 3 people, 12.50%
  5. Infection: 3 people, 12.50%
  6. High Blood Pressure: 3 people, 12.50%
  7. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 12.50%
  8. Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 2 people, 8.33%
  9. Headache (pain in head): 2 people, 8.33%
  10. Ankylosing Spondylitis (type of arthritis affecting the spine): 2 people, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Elavil and Diamox?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Elavil and Diamox:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Elavil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Diamox:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Elavil and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Diamox and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on amitriptyline hydrochloride and acetazolamide (the active ingredients of Elavil and Diamox, respectively), and Elavil and Diamox (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: